In humans, however, monocytes normally express low die rapidly in culture when deprived of exogenous growth factors (Mangan and Wahl, 1991 ; Munn et al., levels of Bcl-2, while neutrophils do not (Iwai et al., 1994 (Iwai et al., ). 1995 . Monocytes from all genotypes were cultured on coverslips in RPMI with or without fetal calf serum supGeneration of op/op hMRP8bcl-2 Mice op/ϩ hMRP8bcl-2/1 and op/ϩ hMRP8bcl-2/2 mice were plemented with L media, which is a medium rich in M-CSF (Stanley et al., 1976; Stanley and Heard, 1977) . bred with op/op and op/ϩ mice. The status of the M-CSF gene in these animals was determined by PCR analysis After 24 hours in culture with no serum, only a few of the control and op/op monocytes survived. hMRP8bcl-(see Experimental Procedures for details) using a modified method developed previously (Lieschke et al., 1994) .
2/1 monocytes demonstrate a slight increase in survival (p Ͻ 0.05), whereas most of the hMRP8bcl-2/2 and op/ Transgenic mice were identified by screening for human Bcl-2 expression in blood cells using flow cytometry.
op hMRP8bcl-2/2 monocytes were viable ( Figure 2A ). In contrast, after 24 hours in culture with serum and L The screening of toothless mice revealed both op/op and op/op hMRP8bcl-2 genotypes. No major changes media, monocytes from all genotypes survived. At 96 hours, when no adherent cells could be detected in in the appearance was observed for both op/op and op/op hMRP8bcl-2 mice. These mice were significantly the control and op/op cultures that were incubated in the absence of serum, most of the adherent cells from smaller and had reduced survival compared to wild-type mice, presumably because the toothless state contribthe hMRP8bcl-2/2 transgenic mice remained viable, whereas very few of the hMRP8bcl-2/1 adherent cells uted mainly to difficulties with nutrition.
survived (not shown). The persisting cells were large, had the morphology of mature macrophages ( Figure  Enforced Expression of hBcl-2 in Monocytes from Wild-Type or op/op Mice Allows 2D), and expressed the macrophage marker F4/80 (Figure 2C) and Mac-1 (not shown). Thus, in these experitheir Survival and Maturation to Macrophages In Vitro ments, monocyte differentiation occurred spontaneously in vitro in the absence of growth factors when cell Monocytes were evaluated for cell survival in the presence or absence of growth factors (Figure 2 ). Monocytes viability is sustained by ectopic expression of Bcl-2. The survival of monocytes was more striking in cells from green fluorescent cell marker, and scored the ratio of viable green (control) to red (hMRP8bcl-2/2) cells adhermice that had high levels of expression of human Bcl-2 (hMRP8bcl-2/2). Even in the presence of serum and L ent to the plastic at 4 and 24 hours. If the hMRP8bcl-2/2 blood cells produced factors that favor the survival media, hMRP8bcl-2/2 monocytes survived better than control monocytes (p Ͻ 0.03). In contrast to monocytes, of adherent monocytic cells, then the ratio of green/ red cells should remain constant. Instead, as shown in bone marrow macrophages isolated from all the different genotypes and cultured for a week in the presence Figure 3E , the initially more numerous green control cells were 71.4% Ϯ 1.6% of adherent viable cells at 4 hours. of growth factors failed to exhibit any survival advantage when growth factors were withdrawn ( Figure 2B ), reHowever, by 24 hours, the vast majority of green control cells had disappeared (only 22.9% Ϯ 13.2% of adherent flecting the absence of transgenic Bcl-2 expression in tissue macrophages ( Figure 1B) . viable cells were green control cells), and the majority of the surviving adherent monocyte/macrophages was It remained possible that monocyte-containing whole blood cell (WBC) cultures from hMRP8bcl-2 mice could derived from the (initially less numerous) Figure 3A ). In addition, op/op addition, tissue macrophages are restored incompletely by 9-12 months of age Mac-1 and Gr-1 to distinguish monocytes from neutrophils (Lagasse and Weissman, 1996) , and F4/80, a pan macrophage marker (Hume et al., 1983) , to identify tisHematological Analysis of op/op hMRP8bcl-2 In peripheral blood, the total white blood cell count was sue macrophages. Flow cytometry and/or immunostaining of frozen sections were performed to detect the normal in all mice analyzed. Yet op/op mice show a slight decrease in the number of circulating monocytes, relative number of neutrophils, monocytes, and macrophages in these different tissues. As shown in Table 1 as has been previously reported elsewhere (WiktorJedrzejczak et al., 1982; Lieschke et al., 1994) . In addiand Figures 3B and 3C , expression of hBcl-2 in monocytes promotes the development of multiple macrotion, we often found an increased number of circulating neutrophils in op/op mice compared to control mice phage subsets in op/op mice. The number of bone marrow cells obtained from the (Table 1 ). The monocyte count of op/op hMRP8bcl-2/2 mice was equivalent to hMRP8bcl-2/2 mice and was long bones of 3-week-old op/op hMRP8bcl-2/2 mice was 1.8 Ϯ 0.5 ϫ 10 7 cells, which was a 10-fold increase significantly elevated compared to control mice (p Ͻ 
Mice were analyzed at 3-6 weeks of age. Data are shown as arithmetic means with standard deviations, and are compiled from groups of 3-5 mice. Statistical comparisons between control and the different genetic constitutions were done using the student's t test. Only the significant values (p Ͻ 0.05) are reported.
over the op/op littermates (0.15 Ϯ 0.01 ϫ 10 7 cells). This antigen expression from peritoneal cells revealed extensive restoration of both macrophage populations from number is similar to the number of cells found in control bone marrow (3.7 Ϯ 0.8 ϫ 10 7 cells). Gr-1/Mac-1 staining op/op hMRP8bcl-2 mice ( Figure 3C ). Finally, Kupffer cells were analyzed in the liver by immunostaining with of the cells revealed monocytosis (Gr-1 lo Mac-1 hi cells) in op/op hMRP8bcl-2/2 mice, when compared to control F4/80 antibodies. As shown in Figure 3B , F4/80-positive Kupffer cells are abnormally low in op/op liver. In conmice (Table 1 ). The monocytosis was remarkably similar to that in hMRP8bcl-2/2 mice and may explain the intrast, the density of Kupffer cells was normal in op/op hMRP8bcl-2/2 and was at intermediate levels in op/op crease of blood monocytes shown in Table 1 . Macrophages (F4/80 hi cells) were also detected in op/op hMRP8bcl-2/1 liver when compared with control and hMRP8bcl-2 mice. hMRP8bcl-2/2 bone marrow at a level equivalent to control bone marrow; this reflected a net increase in bone marrow macrophages compared to op/op mice. The Cell Proliferation Analysis of White Cells Reveals a Long-Lived Bone Marrow Monocyte op/op hMRP8bcl-2/1 mice had only a slight increase in the number of bone marrow cells (0.3 Ϯ 0.1 ϫ 10 7 cells), Population in hMRP8bcl-2/2 Mice The population of nondividing blood monocytes is indicating a limited rescue of bone marrow, as illustrated in Figure 3A . We found evidence of splenomegaly with derived from dividing myelomonocytic precursors in hematopoietic tissues (Balner, 1963 ; van Furth and extramedullary hematopoiesis in op/op and op/op hMRP8bcl-2 of all ages. Flow cytometric analysis of Cohn, 1968) . In control mice, bone marrow myelopoiesis predominates over spleen myelopoiesis ([van Furth and spleen cells from 3-week-old mice revealed an expansion in the myeloid cell compartment, characterized by Cohn, 1968; Volkman A., 1963] and Table 1 ). hMRP8bcl-2/1 mice are much like control mice in terms of monoan increase in neutrophils and monocytes (Table 1). F4/  80 hi splenic macrophage numbers were increased; this cyte numbers in bone marrow, blood, and spleen (Table  1) , but MRP8bcl-2/2 mice have a relative monocytowas confirmed in mice by immunostaining of frozen sections with F4/80 and Mac-1 monoclonal antibodies (not sis in blood, bone marrow, and spleen, and their spleens are actively engaged in hematopoiesis (Lagasse and shown). Peritoneal and pleural macrophages are deficient in young op/op mice. We tested whether Bcl-2 Weissman, unpublished data). If the bone marrow in hMRP8bcl-2/2 mice contained a significant component expression in monocytes could promote maturation of peritoneal macrophages in 3-week-old op/op mice. Periof long-lived monocytes, one might expect that this population would not incorporate 5-bromo-2Ј-deoxyuridine toneal cells were isolated from untreated mice. Approximately 2-to 5-fold fewer cells were recovered from (BrdU) into its DNA. To test this hypothesis, mice were injected with BrdU at time 0 and at 22 hours; from 0-22 op/op hMRP8bcl-2 mice (with a wide variation due to the inherent difficulties of isolation of peritoneal cells) hours, the mice were also allowed to drink water containing BrdU, as described previously (van Furth and when compared to control or hMRP8bcl-2 littermates. At least 10-fold fewer cells were isolated from op/op van Zwet, 1988) . After BrdU was removed, at 8, 24, and 96 hours, the fraction of monocytes in blood, spleen, peritoneal cavities, indicating the scarcity of these cells in these mice. Flow cytometric analysis of F4/80 surface and bone marrow that had gone through at least one S were not measurably in cycle and were not contami- blood to tissues, and so the vast majority of injected cells have left the blood. While most Ly5.1 control white blood cells that persist are not monocytes (0.8%-3.7% phase was assessed by staining with anti-BrdU antibodof control donor cells are monocytes), the relative peries, as described (Carayon and Bord, 1992) . By 8 hours, sistence of Ly5.2 monocytes (as a percentage of Ly5.2 87.3% Ϯ 11.3% of bone marrow monocytes from control donor white cells) ranges from 12%-34% (Table 2) . Thus, and 81.9% Ϯ 15.2% from hMRP8bcl-2/1 mice had lanondividing hMRP8bcl-2/2 monocytes remain as monobeled (Figure 4) , while only 54.0% Ϯ 2.4% of bone marcytes in blood, bone marrow, and spleen to a greater row monocytes from hMRP8bcl-2/2 mice were labeled. degree than do nondividing monocytes from control This indicates the presence of a large pool of nondividLy5.1 donors. In addition, purified blood monocytes ing, longer-lived monocytes in the bone marrow of these sorted from control or hMRP8bcl-2/2 mice were labeled hMRP8bcl-2/2 mice that are less frequent in control and in vitro with Cr and injected IV to determine the resihMRP8bcl-2/1 mice. This difference persists throughout dence time of these cells in the blood and their homing the experimental interval of 8-96 hours post BrdU reto tissues. Greater than 98% of injected labeled cells moval. This difference is not present in blood. We interwere gone from blood by 4 hours, and as expected, the pret this result to mean that newly produced bone marlabel was retained in lung, liver, and spleen (data not row monocytes either migrate to blood or die in normal shown), as previously described for other labeled leukomice, and that the nonmigrants in hMRP8bcl-2/2 bone cyte populations (Gutman and Weissman, 1973 ; Butcher marrow die more slowly. et al., 1980) . Although the whole body 51
Cr count retained at 4 days was slightly but significantly higher (student's hMRP8bcl-2/2 Monocytes Survive Preferentially t test, p Ͻ 0.038 with 4 mice per group) in hMRP8bcl-upon Injection into Normal Hosts 2/2 injected hosts, it was not determined in this experiThe expression of hBcl-2 in myelomonocytic cells could ment if the retained label was present in live progeny enhance monocyte survival and/or cause monocytes to of injected cells. proliferate in vivo. The BrdU incorporation studies shown above provide evidence that hMRP8bcl-2/2 A High Proportion of hMRP8bcl-2/2 Splenic Myeloid monocyte precursors that can enter the blood are prolifCells Can Differentiate to Hepatic Kupffer erating at about the same rate as those in hMRP8bcl-Cells Following Intravenous Injections 2/1 or control mice. To test survival of monocytes indeIn the previous sections, a significant fraction of inputpendent of proliferation, we obtained monocytes that labeled or marked monocytes was found to localize to liver, spleen, and lungs. To test whether the liver label reflected dead or differentiated cells, and to test the potential role of expressed hMRP8bcl-2/2 on these outcomes, 8 ϫ 10 7 PKH26 red-labeled hMRP8bcl-2/2 spleen cells mixed with 5 ϫ 10 8 green control splenocytes were injected into control or op/op hosts. Their spleens and livers were obtained for microscopic analysis 96 hours later ( Figure 5 ). Approximately equal numbers of hMRP8bcl-2/2 and control monocytes (10 7 monocytes) were contained in the inoculum (1:1 red/ green monocytes). By 96 hours, the ratio of red/green cells in the liver was over 50:1 (Figure 5D ), whether the hosts were controls or op/op mice. The hMRP8bcl-2/2 cells in these livers were virtually all Kupffer cells (Figure Silva et al., 1996) . It is possible, of course, whole body label was retained in the liver. We interpret that Bcl-2 can both block apoptosis and play a role these data as evidence that hMRP8bcl-2/2 myelomonoin cell differentiation (Fernandez-Sarabia and Bischoff, cytic cells survive and are permitted to differentiate to 1993; Wang et al., 1994) . That possibility cannot be ruled Kupffer cells in an M-CSF-independent manner, while out until the downstream pathways set in motion by control origin cells that home to the liver die or were Bcl-2 are completely understood. dead, and their 51 Cr-labeled protein, but not the fluores-
The exact in vivo functions of M-CSF has been difficult cent-labeled membrane lipids, is retained in the liver.
to define. The osteopetrotic (op/op) mutant mouse is The viability and homing of other splenic populations devoid of M-CSF and is characterized by a generalized were excellent from both hMRP8bcl-2/2 and control domacrophage and osteoclast deficiency (Marks and nors, as shown by their roughly equal contribution to Lane, 1976; Wiktor-Jedrzejczak et al., 1982 ; Marks, the host splenocyte pool.
1984). Implantation of diffusion chambers containing M-CSF-secreting L-929 cells in the peritoneal cavity of Discussion op/op mice partially corrected the macrophage deficiency (Wiktor-Jedrzejczak et al., 1990) . Injection of reSeveral studies have demonstrated that M-CSF is an combinant M-CSF restored the development of macroessential cytokine for the differentiation of myelomonophages and osteoclasts in these mice (Felix et al., 1990 ; cytic progenitors into macrophages (Metcalf, 1970; Kodama et al., 1991; . Stanley, 1981) . Because growth factors can be required Injection of GM-CSF corrects the macrophage defifor hematopoietic cell survival (Vaux et al., 1988) , it is ciency also, but not the osteopetrosis that results from unclear whether M-CSF is necessary for differentiation a lack of osteoclast-mediated remodeling of bones (Wikof monocytes into macrophages, or survival of monotor-Jedrzejczak et al., 1994). Interestingly, GM-CSF also cytes to the stage at which they respond to intrinsic or corrects pleural and peritoneal macrophage deficienextrinsic stimuli to become macrophages, or both. In cies that were not corrected by similarly administered these studies, monocytes that overexpress the bcl-2 M-CSF, which required local administration for correctransgene remain viable in the absence of M-CSF, while tion. Here, we show that rescuing monocytes from protheir wild-type and op/op counterparts die by apoptosis.
grammed cell death using an intrinsic factor, the protoIn the in vitro cultures of monocytes in the absence of oncogene bcl-2, is capable of correcting macrophage serum or M-CSF described here, the monocytes can deficiencies in op/op mice in a way similar to extrinsic undergo macrophage differentiation, indicating that factors, such as M-CSF and GM-CSF. Although the reexpression of levels of Bcl-2 that block monocyte stored macrophage populations in peritoneal cavities in apoptosis are sufficient for macrophage maturation.
op/op hMRP8bcl-2 mice were quantitatively fewer than These studies suggest a model whereby M-CSF is not in wild-type mice, it clearly indicates that unless prorequired for the induction of monocyte differentiation, vided with tissue-specific survival signals, monocytes but rather promotes differentiation by providing survival undergo spontaneous apoptosis within or upon leaving signals, a function that is essential for maturation of the circulation. Overexpression of Bcl-2 in the myelomacrophages. This model is consistent with previous monocytic lineage and blockade of monocyte cell death studies where maintained viability in different estabhad an incomplete rescue of osteopetrotic lesions: teeth lished in vitro hematopoietic cell lines conferred by expressing anti-apoptotic genes can indirectly result in did not erupt and bone remodeling to form the medullary cavities was incomplete, leaving a spicular network (Figmodel predicts that during normal macrophage production, functional M-CSF/M-CSF receptor engagement is ure 3A). We do not yet know if the failure of dental eruption reflects a fundamentally different mechanism sufficient for only a subset of "naive" monocytes to survive and undergo maturation into morphologically, from bone medullary remodeling, a failure of hMRP8-driven expression of Bcl-2 in monocyte precursors of histochemically, and functionally distinct macrophage populations, depending on their microenvironments. neonatal tooth osteoclasts, a quantitative threshold difference for tooth versus bone, or some as yet undeterWhen macrophage production needs to be increased because of inflammation or infection, M-CSF and other mined mechanism. The osteoclast is a cell that resorbs bone and derives from hematopoietic precursors (Hagecytokines would increase, and many of the monocytes that would ordinarily die survive to expand into macronaars et al., 1989; Hattersley and Chambers, 1989) . The osteoclast population shares several features with other phage populations. We therefore propose that monocyte homeostasis is cells of the mononuclear phagocyte system (MPS); however, its precise cellular ontogeny is unknown, and its significantly regulated by apoptosis and that the principal function of M-CSF in the commitment of blood membership in the MPS is controversial (Lee et al., 1992; Chambers et al., 1993; Grigoriadis et al., 1994) . Our data monocytes to tissue macrophages is to permit survival of monocytic cells, therefore maintaining a pool of these are in agreement with the possibility that osteoclast ontogeny is regulated differently from macrophage oncells able to populate various macrophage compartments. In this model, monocytes kept alive by the action togeny. Here, we propose a model for macrophage ontogeny where survival of monocytes, the macrophage of M-CSF are able to shape the heterogeneity of the macrophage populations through differentiation proprogenitors, is under the influence of M-CSF, the primary tissue-specific regulatory molecule ( Figure 6 ). This cesses that are provided by various cellular microenvironments. This model does not mean, of course, that the high mitogenic potential of M-CSF is not also involved in maintaining the macrophage compartment. M-CSF could be mitogenic for monocyte precursors, and if so, could be involved directly in cell-cycle regulation, or in survival of cells that are or can proliferate, or indirectly, through the secreted or cell-surface mitogens that can be elaborated by cells of the myelomonocytic lineage. MRP8 (and hMRP8bcl-2) is expressed in monocytes, in neutrophils, and likely in an immediate precursor population to both. Thus cell survival, cell proliferation, and factor production by these populations could all play a role in determining the outcomes of enforced Bcl-2 expression in these cells. It is of interest in this regard that the hMRP8bcl-2/2 mice do have increased bone marrow and splenic hematopoiesis (Lagasse and Weissman, unpublished data) . Both survival and proliferation provide the conditions whereby multipotent and lineage-restricted progenitor cells undergo differentiation and development to produce mature cells. In general, it is possible that other cytokines act in the same way in preserving cells at a sensitive stage of differentiation, allowing the surviving cells to respond to other internal or external stimuli during maturation. In a companion publication, we demonstrate that enforced expression of hBcl-2 in lymphoid lineages of IL-7R␣ Ϫ/Ϫ mice largely reverses the extensive defects in thymic and T lymphocyte maturation and homeostasis (but not in the B cell lineage) of these SCID mice (Akashi et al., 1997 [this issue of Cell] ). Thus, in both T lymphopoiesis and monocytopoiesis, a principal function of cytokine/cytokine receptor interaction is the elaboration of signals that permit cell survival.
This model is a potential example of homeostasis by cellular competition for limiting niches where specific cytokines would be accessible for survival and maturation of precursor cells with a predetermined differen- croenvironments. Nevertheless, these features resemstained as previously described (Lagasse and Weissman, 1992) . ble the cellular competition for restricted survival signals Sections were incubated for an hour with F4/80-PE or Mac-1-PE that is well characterized in the nervous system (Oppenmonoclonal antibodies. For bone sections, femurs were decalcified heim, 1991) as well as the cellular competition for follicubefore mounting and sectioning. The formalin-fixed paraffin-embedlar niches in B cell development (Cyster et al., 1994) , ded sections of bone were stained using standard techniques with hematoxylin and eosin.
and has been postulated to be a general mechanism for controlling both cell number and location (Raff, 1992) .
BrdU Labeling
BrdU (Sigma) was administered 24 hours starting by an intraperitoExperimental Procedures neal injection of saline solution containing BrdU (0.8 mg/mouse). BrdU was added in the drinking water at a concentration of 0.8 mg/ Mice ml with 5% glucose to overcome taste aversion. At 22 hours, a op/op hMRP8bcl-2 transgenic mice were generated by initial breedsecond dose of BrdU was administered intraperitoneally and regular ing of hMRP8bcl-2 transgenic mice (C57Bl/Thy1.1) (Lagasse and drinking water was added. The free BrdU is cleared by 1-2 hr after Weissman, 1994) with op/ϩ mice (M-CSF Ϫ/ϩ or CSF-1 Ϫ/ϩ ) obtained injection, giving 24 hr of BrdU incorporation. To detect BrdU in from Jackson Laboratories (Bar Harbor, Maine), followed by op/ϩ monocytes, cells were first stained with directly labeled antibodies hMRP8bcl-2 mice with op/ϩ mice interbreeding. All mice presented (Biotinylated-Gr-1, APC-conjugated Mac-1, and PE-conjugated F4/ in this analysis have been backcrossed to the transgenic strain for 80 [Caltag] ), fixed in Tween 20-containing paraformaldehyde folmore than 3 generations and were homozygous for Thy1.1. Mice lowed by bovine pancreatic DNAse I treatment as described prewere bred and maintained at Stanford University Medical School, viously (Carayon and Bord, 1992 (Lieschke et al., 1994) .
Cell Labeling In brief, PCR reactions (10 l) containing 100 ng of tail DNA, 50 mM Blood and spleen cells were labeled with PKH2-GL and PKH26-GL KCl, 10 mM Tris (pH 8.3), 1.5 mM MgCl 2 , 0.1% gelatin w/v, 200 mM (Sigma) using in vitro labeling methods described by the manufacdNTP, 12.5 ng of primers, 1 U of Taq polymerase, and 10 Ci of [␣-
35 S] ture. Labeled blood cells were cultured as described for the viability dATP (Amersham Life Science) were incubated at 96ЊC for 1 min, assay. Labeled spleen cells were injected IV 96 hr later, mice were 55ЊC for 2 min, and 72ЊC for 2 min for 30 cycles. The PCR reaction sacrified, and spleen and liver were embedded in O. C. T. (Tissuegenerated radiolabeled DNA fragments of 195 bp or 196 bp, deTek). Cryostat section (10 m) were analyzed under fluorescent pending on the op mutation. In addition, the 2-bp mismatch in one microscope (Nikon) using a dual Texas Red/FITC filter. of the primers introduced a second BglI site for the op mutation. PCR products digested with BglI in a total volume of 20 l, generated Acknowledgments three different patterns, depending on the genotype of the mouse. These small fragments were separated by electrophoresis in 20%
Correspondence regarding this paper should be addressed to E. L. nondenaturing acrylamide gel. Gels were dried and exposed over-(Lagasse@cmgm.stanford.edu). We thank Libuse Jerabek for labonight. ratory management, Veronica Braunstein for antibody preparation, Lucino Hidalgo for animal care, and Marilyn Masek for liver and Viability Assay bone sections. Thanks to David Traver, Chris Klug, Douglas Wright, Monocyte viability: white blood cells (WBC, 10 6 cells/ml, 1 ml/well and Jos Domen for critical reading of the manuscript. This work in a 24-well plate) were cultured on cover glasses for 4 hr in the was supported by a grant from SyStemix/Sandoz. presence of serum, then adherent cells (monocytes) were further cultured in the presence or absence of growth factors (10% Serum and 10% L media, an L-929 cell-conditioned medium rich in M-CSF).
Received February 24, 1997; revised May 12, 1997. Viability of monocytes was evaluated by acridine orange and ethidium bromide staining (Coligan et al., 1991) and presented as a perReferences centage of total viable adherent monocytes present at 4 hr of culture. Macrophage viability: adherent bone marrow cells from control and Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R., and Weisstransgenic mice were cultured for a week to confluency in presence man, I.L. (1997) . Bcl-2 rescues T lymphopoiesis in interleukin-7 reof serum and L media, then macrophages were further cultured in ceptor-deficient mice. Cell, this issue. absence of growth factors and their viability was evaluated as above. Balner, H. (1963) . Identification of peritoneal macrophages in mouse radiation chimeras. Transplantation 1, 217-223.
Flow Cytometry
Butcher, E.C., Scollay, R.G., and Weissman, I.L. (1980) . Direct fluoCell suspensions from the different tissues as well as surface marker rescent labeling of cells with fluorescein or rhodamine isothiocyastaining were performed as previously described (Lagasse and nate. II. Potential application to studies of lymphocyte migration Weissman, 1996) using the following monoclonal antibodies (MAbs):
and maturation. J. Immunol. Meth. 37, 109-121. Mac-1 and Gr-1, directly conjugated with phycoerythrin (PE) (MolecByrne, P.V., Guilbert, L.J., and Stanley, E.R. (1981) 
